TP53 and cancer: According to the western blot analysis, we demonstrated the most active compound 11b effectively and simultaneously inhibited MDM2 and HDAC through up-regulating the expression of p53 and Ac-H4 in MCF-7 cancer cells in a dose-dependent manner.